These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 16036872

  • 1. Effects of medical therapy on pituitary tumors.
    Kovacs K, Horvath E.
    Ultrastruct Pathol; 2005; 29(3-4):163-7. PubMed ID: 16036872
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 3. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A, Sanno N, Tahara S, Osamura YR.
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [Abstract] [Full Text] [Related]

  • 4. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
    Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
    [Abstract] [Full Text] [Related]

  • 5. [Novel pharmacologic therapies in acromegaly].
    Góth M, Hubina E, Kovács L, Szabolcs I.
    Orv Hetil; 2002 May 12; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [Abstract] [Full Text] [Related]

  • 6. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G, Ferdeghini M, Bellina CR, Matteucci F, Castro Lopez E, Parenti G, Canapicchi R, Bianchi R.
    Q J Nucl Med; 1995 Dec 12; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [Abstract] [Full Text] [Related]

  • 7. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J.
    J Clin Endocrinol Metab; 1992 Aug 12; 75(2):540-6. PubMed ID: 1353505
    [Abstract] [Full Text] [Related]

  • 8. New perspectives in the medical treatment of acromegaly.
    Colao A, Pivonello R, Auriemma RS, Galdiero M, Guerra E, Milone F, De Leo M, Lombardi G.
    J Endocrinol Invest; 2005 Aug 12; 28(11 Suppl International):58-66. PubMed ID: 16625847
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec 12; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 10. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U, Reichel M, Fett U, Saeger W, Quabbe HJ.
    J Clin Endocrinol Metab; 1994 Nov 12; 79(5):1416-23. PubMed ID: 7962337
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun 12; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 12. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy.
    Lamberts SW, Hofland LJ, de Herder WW, Kwekkeboom DJ, Reubi JC, Krenning EP.
    Front Neuroendocrinol; 1993 Jan 12; 14(1):27-55. PubMed ID: 8097480
    [Abstract] [Full Text] [Related]

  • 13. Clinical review 110: Diagnosis and treatment of pituitary tumors.
    Freda PU, Wardlaw SL.
    J Clin Endocrinol Metab; 1999 Nov 12; 84(11):3859-66. PubMed ID: 10566620
    [Abstract] [Full Text] [Related]

  • 14. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.
    Thyroid; 2015 Aug 12; 25(8):877-82. PubMed ID: 26244412
    [Abstract] [Full Text] [Related]

  • 15. Management of pituitary tumors.
    Shimon I, Melmed S.
    Ann Intern Med; 1998 Sep 15; 129(6):472-83. PubMed ID: 9735086
    [Abstract] [Full Text] [Related]

  • 16. Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma.
    Müssig K, Gallwitz B, Honegger J, Strasburger CJ, Bidlingmaier M, Machicao F, Bornemann A, Ranke MB, Häring HU, Petersenn S.
    Exp Clin Endocrinol Diabetes; 2007 Mar 15; 115(3):198-202. PubMed ID: 17427111
    [Abstract] [Full Text] [Related]

  • 17. Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs.
    Matrone C, Pivonello R, Colao A, Cappabianca P, Cavallo LM, Del Basso De Caro ML, Taylor JE, Culler MD, Lombardi G, Di Renzo GF, Annunziato L.
    Neuroendocrinology; 2004 Mar 15; 79(3):142-8. PubMed ID: 15103227
    [Abstract] [Full Text] [Related]

  • 18. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M, Fortunato M, Molteni L, Peretti E, Mortini P.
    Minerva Endocrinol; 2008 Dec 15; 33(4):329-40. PubMed ID: 18923369
    [Abstract] [Full Text] [Related]

  • 19. Correlation of in vitro and in vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopy.
    Ferone D, de Herder WW, Pivonello R, Kros JM, van Koetsveld PM, de Jong T, Minuto F, Colao A, Lamberts SW, Hofland LJ.
    J Clin Endocrinol Metab; 2008 Apr 15; 93(4):1412-7. PubMed ID: 18211974
    [Abstract] [Full Text] [Related]

  • 20. Medical management of growth hormone-secreting pituitary adenomas.
    Racine MS, Barkan AL.
    Pituitary; 2002 Apr 15; 5(2):67-76. PubMed ID: 12675503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.